• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LAT1转运机制的原子水平描述。

Description of LAT1 Transport Mechanism at an Atomistic Level.

作者信息

Palazzolo Luca, Parravicini Chiara, Laurenzi Tommaso, Guerrini Uliano, Indiveri Cesare, Gianazza Elisabetta, Eberini Ivano

机构信息

Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy.

Dipartimento di Biologia, Ecologia e Scienze della Terra, University of Calabria, Cosenza, Italy.

出版信息

Front Chem. 2018 Aug 24;6:350. doi: 10.3389/fchem.2018.00350. eCollection 2018.

DOI:10.3389/fchem.2018.00350
PMID:30197880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6117385/
Abstract

The molecular mechanism of transport mediated by LAT1, a sodium-independent antiporter of large neutral amino acids, was investigated through procedures, specifically making reference to two transported substrates, tyrosine (Tyr) and leucine methyl ester (LME), and to 3,5-diiodo-L-tyrosine (DIT), a well-known LAT1 inhibitor. Two models of the transporter were built by comparative modeling, with LAT1 either in an outward-facing (OF) or in an inward-facing (IF) conformation, based, respectively, on the crystal structure of AdiC and of GadC. As frequently classic Molecular Dynamics (MD) fails to monitor large-scale conformational transitions within a reasonable simulated time, the OF structure was equilibrated for 150 ns then processed through targeted MD (tMD). During this procedure, an elastic force pulled the OF structure to the IF structure and induced, at the same time, substrates/inhibitor to move through the transport channel. This elastic force was modulated by a spring constant () value; by decreasing its value from 100 to 70, it was possible to comparatively account for the propensity for transport of the three tested molecules. In line with our expectations, during the tMD simulations, Tyr and LME behaved as substrates, moving down the transport channel, or most of it, for all values. On the contrary, DIT behaved as an inhibitor, being (almost) transported across the channel only at the highest value (100). During their transit through the channel, Tyr and LME interacted with specific amino acids (first with Phe252 then with Thr345, Arg348, Tyr259, and Phe262); this suggests that a primary as well as a putative secondary gate may contribute to the transport of substrates. Quite on the opposite, DIT appeared to establish only transient interactions with side chains lining the external part of the transport channel. Our tMD simulations could thus efficiently discriminate between two transported substrates and one inhibitor, and therefore can be proposed as a benchmark for developing novel LAT1 inhibitors of pharmacological interest.

摘要

通过相关程序研究了LAT1(一种大型中性氨基酸的钠非依赖性反向转运体)介导的转运分子机制,特别参考了两种转运底物,即酪氨酸(Tyr)和亮氨酸甲酯(LME),以及一种著名的LAT1抑制剂3,5 - 二碘 - L - 酪氨酸(DIT)。基于AdiC和GadC的晶体结构,通过比较建模构建了两种转运体模型,分别为外向构象(OF)和内向构象(IF)的LAT1。由于经典分子动力学(MD)常常无法在合理的模拟时间内监测大规模构象转变,因此对OF结构进行了150纳秒的平衡,然后通过靶向分子动力学(tMD)进行处理。在此过程中,一个弹性力将OF结构拉向IF结构,同时诱导底物/抑制剂通过转运通道移动。该弹性力由弹簧常数()值调节;通过将其值从100降至70,可以比较三种测试分子的转运倾向。正如我们所预期的,在tMD模拟过程中,Tyr和LME表现为底物,在所有值下都沿着转运通道或其大部分移动。相反,DIT表现为抑制剂,仅在最高值(100)时(几乎)穿过通道。在它们通过通道的过程中,Tyr和LME与特定氨基酸相互作用(首先与Phe252相互作用,然后与Thr345、Arg348、Tyr259和Phe262相互作用);这表明一个主要以及一个假定的次要门控可能有助于底物的转运。恰恰相反,DIT似乎仅与位于转运通道外部的侧链建立短暂相互作用。因此,我们的tMD模拟可以有效地区分两种转运底物和一种抑制剂,因此可以作为开发具有药理学意义的新型LAT1抑制剂的基准。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad0/6117385/e0dea251c555/fchem-06-00350-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad0/6117385/07b11dea8d11/fchem-06-00350-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad0/6117385/bb8313ed390f/fchem-06-00350-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad0/6117385/489b5b75f9ed/fchem-06-00350-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad0/6117385/79ae79272922/fchem-06-00350-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad0/6117385/4690f49daf06/fchem-06-00350-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad0/6117385/c8b507bc20e8/fchem-06-00350-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad0/6117385/bc246d3c7fbd/fchem-06-00350-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad0/6117385/0ff03dca39b5/fchem-06-00350-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad0/6117385/e0dea251c555/fchem-06-00350-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad0/6117385/07b11dea8d11/fchem-06-00350-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad0/6117385/bb8313ed390f/fchem-06-00350-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad0/6117385/489b5b75f9ed/fchem-06-00350-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad0/6117385/79ae79272922/fchem-06-00350-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad0/6117385/4690f49daf06/fchem-06-00350-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad0/6117385/c8b507bc20e8/fchem-06-00350-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad0/6117385/bc246d3c7fbd/fchem-06-00350-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad0/6117385/0ff03dca39b5/fchem-06-00350-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad0/6117385/e0dea251c555/fchem-06-00350-g0009.jpg

相似文献

1
Description of LAT1 Transport Mechanism at an Atomistic Level.LAT1转运机制的原子水平描述。
Front Chem. 2018 Aug 24;6:350. doi: 10.3389/fchem.2018.00350. eCollection 2018.
2
Mechanism of substrate transport and inhibition of the human LAT1-4F2hc amino acid transporter.人LAT1-4F2hc氨基酸转运体的底物转运及抑制机制
Cell Discov. 2021 Mar 23;7(1):16. doi: 10.1038/s41421-021-00247-4.
3
Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET.肿瘤上调的 L 型氨基酸转运蛋白 1 对 3-氟-L-α-甲基酪氨酸的转运:导致 PET 肿瘤摄取的原因。
J Nucl Med. 2012 Aug;53(8):1253-61. doi: 10.2967/jnumed.112.103069. Epub 2012 Jun 28.
4
Insights into the Transport Cycle of LAT1 and Interaction with the Inhibitor JPH203.LAT1 转运周期的研究进展及其与抑制剂 JPH203 的相互作用
Int J Mol Sci. 2023 Feb 17;24(4):4042. doi: 10.3390/ijms24044042.
5
Involvement of LAT1 and LAT2 in the high- and low-affinity transport of L-leucine in human retinal pigment epithelial cells (ARPE-19 cells).LAT1 和 LAT2 参与人视网膜色素上皮细胞(ARPE-19 细胞)中 L-亮氨酸的高亲和性和低亲和性转运。
J Pharm Sci. 2010 May;99(5):2475-82. doi: 10.1002/jps.21991.
6
The Human SLC7A5 (LAT1): The Intriguing Histidine/Large Neutral Amino Acid Transporter and Its Relevance to Human Health.人类溶质载体家族7成员5(LAT1):引人入胜的组氨酸/大型中性氨基酸转运体及其与人类健康的关联。
Front Chem. 2018 Jun 22;6:243. doi: 10.3389/fchem.2018.00243. eCollection 2018.
7
Stimulation of 125I-3-iodo-alpha-methyl-L-tyrosine uptake in Chinese hamster ovary (CHO-K1) cells by tyrosine esters.中文仓鼠卵巢(CHO-K1)细胞中酪氨酸酯对 125I-3-碘-α-甲基-L-酪氨酸摄取的刺激作用。
Nucl Med Biol. 2010 Feb;37(2):189-96. doi: 10.1016/j.nucmedbio.2009.10.003. Epub 2009 Nov 3.
8
Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.T24人膀胱癌细胞中系统L氨基酸转运体的特性研究
Biochim Biophys Acta. 2002 Sep 20;1565(1):112-21. doi: 10.1016/s0005-2736(02)00516-3.
9
System L amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-L-tyrosine (FET).系统L氨基酸转运体LAT1会积累O-(2-氟乙基)-L-酪氨酸(FET)。
Amino Acids. 2015 Feb;47(2):335-44. doi: 10.1007/s00726-014-1863-3. Epub 2014 Nov 11.
10
Uptake of 3-[125I]iodo-alpha-methyl-L-tyrosine into colon cancer DLD-1 cells: characterization and inhibitory effect of natural amino acids and amino acid-like drugs.125I-碘-α-甲基-L-酪氨酸在结肠癌细胞 DLD-1 中的摄取:天然氨基酸和氨基酸类似物药物的特征及抑制作用。
Nucl Med Biol. 2010 Feb;37(2):197-204. doi: 10.1016/j.nucmedbio.2009.10.011. Epub 2009 Nov 26.

引用本文的文献

1
Atomistic description of the OCTN1 recognition mechanism via in silico methods.通过计算机模拟方法对 OCTN1 识别机制的原子水平描述。
PLoS One. 2024 Jun 3;19(6):e0304512. doi: 10.1371/journal.pone.0304512. eCollection 2024.
2
In Silico Description of the Direct Inhibition Mechanism of Endothelial Lipase by ANGPTL3.ANGPTL3 对内皮脂肪酶直接抑制作用的计算机模拟描述。
Int J Mol Sci. 2024 Mar 21;25(6):3555. doi: 10.3390/ijms25063555.
3
Comparison of Experimental Strategies to Study l-Type Amino Acid Transporter 1 (LAT1) Utilization by Ligands.

本文引用的文献

1
The Human SLC7A5 (LAT1): The Intriguing Histidine/Large Neutral Amino Acid Transporter and Its Relevance to Human Health.人类溶质载体家族7成员5(LAT1):引人入胜的组氨酸/大型中性氨基酸转运体及其与人类健康的关联。
Front Chem. 2018 Jun 22;6:243. doi: 10.3389/fchem.2018.00243. eCollection 2018.
2
Effects of Mutations and Ligands on the Thermostability of the l-Arginine/Agmatine Antiporter AdiC and Deduced Insights into Ligand-Binding of Human l-Type Amino Acid Transporters.突变和配体对 l-精氨酸/胍丁胺反向转运蛋白 AdiC 热稳定性的影响及对人 l 型氨基酸转运蛋白配体结合的推断。
Int J Mol Sci. 2018 Mar 20;19(3):918. doi: 10.3390/ijms19030918.
3
比较研究配体对 l 型氨基酸转运蛋白 1(LAT1)利用的实验策略。
Molecules. 2021 Dec 22;27(1):37. doi: 10.3390/molecules27010037.
4
Photo-Switchable Sulfonylureas Binding to ATP-Sensitive Potassium Channel Reveal the Mechanism of Light-Controlled Insulin Release.光控胰岛素释放的机制研究:对 ATP 敏感性钾通道具有光切换作用的磺酰脲类化合物。
J Phys Chem B. 2021 Dec 9;125(48):13111-13121. doi: 10.1021/acs.jpcb.1c07292. Epub 2021 Nov 26.
5
Demystifying the Molecular Basis of Pyrazoloquinolinones Recognition at the Extracellular α1+/β3- Interface of the GABA Receptor by Molecular Modeling.通过分子建模揭示吡唑并喹啉酮在GABA受体细胞外α1+/β3-界面识别的分子基础
Front Pharmacol. 2020 Sep 11;11:561834. doi: 10.3389/fphar.2020.561834. eCollection 2020.
6
ATP modulates SLC7A5 (LAT1) synergistically with cholesterol.三磷酸腺苷与胆固醇协同调节溶质载体家族 7 成员 5(LAT1)。
Sci Rep. 2020 Oct 7;10(1):16738. doi: 10.1038/s41598-020-73757-y.
7
Function and Regulation of Acid Resistance Antiporters.耐酸转运蛋白的功能与调控。
J Membr Biol. 2019 Oct;252(4-5):465-481. doi: 10.1007/s00232-019-00073-6. Epub 2019 Jun 25.
Identification of small molecules uncoupling the Notch::Jagged interaction through an integrated high-throughput screening.
通过整合的高通量筛选鉴定解除Notch::Jagged相互作用的小分子。
PLoS One. 2017 Nov 3;12(11):e0182640. doi: 10.1371/journal.pone.0182640. eCollection 2017.
4
Potent inhibitors of human LAT1 (SLC7A5) transporter based on dithiazole and dithiazine compounds for development of anticancer drugs.基于二噻唑和二噻嗪化合物的人LAT1(SLC7A5)转运蛋白强效抑制剂,用于抗癌药物开发。
Biochem Pharmacol. 2017 Nov 1;143:39-52. doi: 10.1016/j.bcp.2017.07.006. Epub 2017 Jul 12.
5
GPNA inhibits the sodium-independent transport system L for neutral amino acids.甘氨酰脯氨酰-双肽氨肽酶抑制中性氨基酸的非钠依赖转运系统L。
Amino Acids. 2017 Aug;49(8):1365-1372. doi: 10.1007/s00726-017-2436-z. Epub 2017 May 17.
6
Novel insights into the transport mechanism of the human amino acid transporter LAT1 (SLC7A5). Probing critical residues for substrate translocation.深入了解人氨基酸转运蛋白 LAT1(SLC7A5)的转运机制。探究底物转运的关键残基。
Biochim Biophys Acta Gen Subj. 2017 Apr;1861(4):727-736. doi: 10.1016/j.bbagen.2017.01.013. Epub 2017 Jan 11.
7
Alternating access mechanisms of LeuT-fold transporters: trailblazing towards the promised energy landscapes.LeuT 折叠转运蛋白的交替存取机制:开拓通向有希望的能量景观之路。
Curr Opin Struct Biol. 2017 Aug;45:100-108. doi: 10.1016/j.sbi.2016.12.006. Epub 2016 Dec 30.
8
Impaired Amino Acid Transport at the Blood Brain Barrier Is a Cause of Autism Spectrum Disorder.血脑屏障处氨基酸转运受损是自闭症谱系障碍的一个病因。
Cell. 2016 Dec 1;167(6):1481-1494.e18. doi: 10.1016/j.cell.2016.11.013.
9
SLC Transporters: Structure, Function, and Drug Discovery.溶质载体转运蛋白:结构、功能与药物发现
Medchemcomm. 2016 Jun 1;7(6):1069-1081. doi: 10.1039/C6MD00005C. Epub 2016 Mar 28.
10
LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substrates.羧酸生物电子等排体的LAT1活性:异羟肟酸作为底物的评估。
Bioorg Med Chem Lett. 2016 Oct 15;26(20):5000-5006. doi: 10.1016/j.bmcl.2016.09.001. Epub 2016 Sep 3.